Literature DB >> 17982098

Catalytically inactive cyclooxygenase 2 and absence of prostaglandin E2 biosynthesis in murine peritoneal macrophages following in vivo phagocytosis of heat-killed Mycobacterium bovis bacillus Calmette-Guérin.

Makiko Yamashita1, Tsutomu Shinohara, Shoutaro Tsuji, Quentin N Myrvik, Akihito Nishiyama, Ruth Ann Henriksen, Yoshimi Shibata.   

Abstract

Over 25 years ago, it was observed that peritoneal macrophages (Mphi) isolated from mice given heat-killed Mycobacterium bovis bacillus Calmette-Guérin (HK-BCG) i.p. did not release PGE(2). However, when peritoneal Mphi from untreated mice are treated with HK-BCG in vitro, cyclooxygenase 2 (COX-2), a rate-limiting enzyme for PGE(2) biosynthesis, is expressed and the release of PGE(2) is increased. The present study of peritoneal Mphi obtained from C57BL/6 mice and treated either in vitro or in vivo with HK-BCG was undertaken to further characterize the cellular responses that result in suppression of PGE(2) release. The results indicate that Mphi treated with HK-BCG in vivo express constitutive COX-1 and inducible COX-2 that are catalytically inactive, are localized subcellularly in the cytoplasm, and are not associated with the nuclear envelope (NE). In contrast, Mphi treated in vitro express catalytically active COX-1 and COX-2 that are localized in the NE and diffusely in the cytoplasm. Thus, for local Mphi activated in vivo by HK-BCG, the results indicate that COX-1 and COX-2 dissociated from the NE are catalytically inactive, which accounts for the lack of PGE(2) production by local Mphi activated in vivo with HK-BCG. Our studies further indicate that the formation of catalytically inactive COX-2 is associated with in vivo phagocytosis of HK-BCG, and is not dependent on extracellular mediators produced by in vivo HK-BCG treatment. This attenuation of PGE(2) production may enhance Mphi-mediated innate and Th1-acquired immune responses against intracellular infections which are suppressed by PGE(2).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982098     DOI: 10.4049/jimmunol.179.10.7072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Chitin particles induce size-dependent but carbohydrate-independent innate eosinophilia.

Authors:  Mari Kogiso; Akihito Nishiyama; Tsutomu Shinohara; Masataka Nakamura; Emiko Mizoguchi; Yoshinori Misawa; Elisabeth Guinet; Mahyar Nouri-Shirazi; C Kathleen Dorey; Ruth Ann Henriksen; Yoshimi Shibata
Journal:  J Leukoc Biol       Date:  2011-03-29       Impact factor: 4.962

2.  Cholera toxin induces a shift from inactive to active cyclooxygenase 2 in alveolar macrophages activated by Mycobacterium bovis BCG.

Authors:  Mari Kogiso; Tsutomu Shinohara; C Kathleen Dorey; Yoshimi Shibata
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

3.  Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.

Authors:  Murugesan V S Rajaram; Michelle N Brooks; Jessica D Morris; Jordi B Torrelles; Abul K Azad; Larry S Schlesinger
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

4.  Role of PPARγ in COX-2 activation in mycobacterial pulmonary inflammation.

Authors:  Mari Kogiso; Tsutomu Shinohara; C Kathleen Dorey; Yoshimi Shibata
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

5.  Persistent inactivation of macrophage cyclooxygenase-2 in mycobacterial pulmonary inflammation.

Authors:  Tsutomu Shinohara; Traci Pantuso; Shizuka Shinohara; Mari Kogiso; Quentin N Myrvik; Ruth Ann Henriksen; Yoshimi Shibata
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

6.  A small hairpin RNA targeting myeloid cell leukemia-1 enhances apoptosis in host macrophages infected with Mycobacterium tuberculosis.

Authors:  Fei-yu Wang; Yu-qing Zhang; Xin-min Wang; Chan Wang; Xiao-fang Wang; Jiang-dong Wu; Fang Wu; Wan-jiang Zhang; Le Zhang
Journal:  J Microbiol       Date:  2016-04-01       Impact factor: 3.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.